Skip to main content

Tofacitinib

NDC 51991-963 · Breckenridge Pharmaceutical, Inc.

Generic nameTofacitinib Citrate
Dosage formTABLET
RouteORAL
Active ingredient(s)TOFACITINIB CITRATE
Strength10 mg/1
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryANDA

Packages

51991-963-06 — 60 TABLET in 1 BOTTLE (51991-963-06)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0069-1029 — tofacitinib, 0574-1811 — Tofacitinib Citrate, 27241-270 — Tofacitinib, 33342-541 — Tofacitinib, 33342-542 — Tofacitinib, 42571-268 — tofacitinib, 42571-377 — tofacitinib, 42799-970 — Tofacitinib, 50228-567 — Tofacitinib citrate, 51991-329 — Tofacitinib Citrate, 59651-459 — TOFACITINIB, 59651-460 — TOFACITINIB, 59651-685 — TOFACITINIB, 60505-4858 — tofacitinib, 63539-012 — tofacitinib, 63539-016 — tofacitinib, 63539-029 — tofacitinib, 63539-501 — tofacitinib, 63539-502 — tofacitinib, 70069-841 — TOFACITINIB, +27 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.